Kingworld Medicines Group Limited (01110.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 0.39

From 52W high−38.33%

Volume1.50M

Market capHKD 230.00M

P/E (TTM)16.7x

P/S (TTM)0.2x

Div yield—

Key dataSep 18, 2026

Open

HKD 0.39

From 52W high

−38.33%

Volume

1.50M

Market cap

HKD 230.00M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

6.7x

P/E (TTM)

16.7x

RSI (14)

35.3

MomentumView details →

1D Return

−3.90%

YTD Return

−28.85%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

16.7x

EV/EBITDA

6.7x

EV/Sales

0.6x

P/S (TTM)

0.2x

P/B (TTM)

0.3x

ProfitabilityView details →

Gross Margin

30.47%

Net Margin

1.46%

EBITDA Margin

9.53%

ROE (TTM)

1.92%

ROA (TTM)

0.88%

Asset Turnover

0.57x

GrowthView details →

Revenue YoY

−16.17%

EPS YoY

+90.91%

FCF YoY

+726.29%

Revenue CAGR 3Y

−1.42%

EPS CAGR 3Y

−20.00%

EBITDA YoY

+32.62%

MomentumView details →

1D Return

−3.90%

YTD Return

−28.85%

1Y Return

−31.48%

RSI (14)

35.3

vs 50D SMA

−14.33%

vs 200D SMA

−21.48%

Capital & dividendView details →

Debt/Equity

0.73x

Current Ratio

1.05x

Quick Ratio

0.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

−6.21%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.73B

Net Income (TTM)

16.90M

Op. CF (TTM)

57.02M

Latest newsMore news →

Kingworld Medicines Group announced its interim results for the six months ended June 30, 2026, with revenue of 275 million RMB, down 32% year-on-year, net loss narrowing from 5.41 million RMB in the prior-year period to 5.22 million RMB, loss per share of 0.9 cents, and no dividend.24d ago

Similar companies

High Tide Inc.HITI Tycoon Group Holdings Limited03390.HK Satellos Bioscience Inc. Common StockMSLE Vicore Pharma Holding ABVCRE Clinuvel Pharmaceuticals Ltd.CUVL LifeMD, Inc.LFMD Find similar companies →

Latest newsMore news →

Kingworld Medicines Group announced its interim results for the six months ended June 30, 2026, with revenue of 275 million RMB, down 32% year-on-year, net loss narrowing from 5.41 million RMB in the prior-year period to 5.22 million RMB, loss per share of 0.9 cents, and no dividend.24d ago